← All compounds
peptide32 listings
Cagrilintide
Long-Acting Amylin Analog
Amylin analog. Often researched alongside GLP-1 compounds for synergistic effects.
Metabolic researchWeight management
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★★☆
4/5 — Quality of evidence
Phase 2 trials show strong metabolic effects. Amylin pathway adds to GLP-1 effects.
/ mechanism of action
How it works
Amylin receptor agonist. Slows gastric emptying, reduces appetite via different pathway than GLP-1.
/ research dosing
Common research protocols
Range
0.3 → 0.6 → 1.2 → 2.4 mg/week (with sema/tirz) up to 4.5mg/week
Frequency
Once weekly subcutaneous
Route
Subcutaneous
Cycle
Start 0.3mg/week → titrate every 4 weeks → maintenance 2.4-4.5mg/week
Research notes
Amylin analog often paired with semaglutide (CagriSema) or tirzepatide. Adds satiety and slows gastric emptying via different pathway than GLP-1. Increases GI side effects when combined with GLP-1s — slow titration essential.
References
PMID: 33388088 →Novo Nordisk Phase 2 trials
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Effective standalone. Amylin pathway is independent of GLP-1.
Common pairings
/ side effects
What to know
Common: GI adjustment.
/ timeline
Realistic expectations
Effects within 4-8 weeks
/ recommendation
Where to buy Cagrilintide
🏆Our pick for Cagrilintide
Modern Research Peptides
10mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. Cagrilintide is intended for laboratory research and not for human consumption.